IP Library › Granted Patent US 12,263,187
Granted Patent B2
US 12,263,187 · App. 18/116,417 · Granted Apr 1, 2025

Treatment of bone marrow pathologies with polysulfated polysaccharides

Inventors: Ravi Krishnan (Royston Park, AU); Paul Rennie (West Beach, AU)
Assignee: PARADIGM BIOPHARMACEUTICALS LTD
A61K31/737A61K9/0019A61P19/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,263,187
App. No.
18/116,417
Granted
Apr 1, 2025
Kind
B2
Abstract

The present invention relates to the medical use of polysulfated polysaccharides and compositions thereof for the treatment of disease or disorders associated with bone marrow pathologies in the musculoskeletal system of a mammal. In particular, the invention relates to use of polysulfated polysaccharides, such as pentosan polysulfate, in treatment of bone marrow edema lesions or spinal Modic Endplate Changes as assessed by magnetic resonance imaging (MRI).

Claims (13)

1. A method for improving knee function and reducing knee pain in a human having osteoarthritis 3-4 on the Kellgren-Lawrence scale in a knee and experiencing pain of at least 8 on the NRS scale, the method including determining that treatment of the knee with a corticosteroid has failed to improve knee function and reduce pain and administering intramuscularly an amount of an acceptable salt of pentosan polysulfate, to the human in need of such treatment, in a manner so as to improve knee function by about 23% to about 89% as determined by Lysholm Knee Score.

2. The method according to claim 1 , wherein the pentosan polysulfate (PPS) is selected from the group consisting of: the sodium salt of pentosan polysulfate (NaPPS), the magnesium salt of pentosan polysulfate (MgPPS), the calcium salt of pentosan polysulfate (CaPPS), and the zinc salt of pentosan polysulfate (ZnPPS).

3. The method according to claim 2 , wherein the pentosan polysulfate (PPS) is sodium pentosan polysulfate (NaPPS).

4. The method according to claim 3 , wherein the treatment is by administering the sodium pentosan polysulfate or the acceptable salt thereof to the human in an effective amount of about 1 to 2 mg/kg of the human per dose or an effective amount of between about 25 mg and 300 mg as a fixed dose.

5. The method according to claim 3 , wherein the treatment is by administering the sodium pentosan polysulfate or the acceptable salt thereof to the human in an effective amount of about 2 mg/kg of the human per dose or an effective amount of about 150 mg as a fixed dose.

6. The method according to claim 3 , wherein administration is by dosing in a treatment regimen once daily, twice weekly or thrice weekly.

7. The method according to claim 6 , wherein administration is by dosing in a treatment regimen twice weekly.

8. The method according to claim 7 , wherein administration is by dosing in a treatment regimen twice weekly with a minimum of three days and a maximum of four days between dosages.

9. The method according to claim 8 , wherein administration is by dosing in a treatment regimen twice weekly for six weeks.

10. The method according to claim 9 , wherein the total dose of the sodium pentosan polysulfate or the acceptable salt thereof administered in the treatment regimen is about 200 to 4000 mg.

11. The method according to claim 1 , wherein the function of the knee is improved by about 23% to about 35%.

12. The method according to claim 1 , wherein the function of the knee is improved by about 23 to about 43%.

13. The method according to claim 1 , wherein the function of the knee is improved about 89%.

Assignments (2)
CORRECTION BY DECLARATION OF ERRONEOUSLY FILED ASSIGNMENT Recorded Dec 18, 2025
From: PARADIGM BIOPHARMAC EUTICALS LTD.
To: PARADIGM BIOPHARMAC EUTICALS LTD.
Reel/Frame 074003/0892 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2023
From: KRISHNAN, RAVI; RENNIE, PAUL
To: PARADIGM BIOPHARMACEUTICALS LTD
Reel/Frame 063088/0378 →
Priority Claims (1)
AU 2017903094 · Aug 4, 2017 · national
Continuity (2)
Continuation 16636545
Related Publication 20230241099A1 · Aug 3, 2023
References Cited (90)
US 9101650B2 · Ghosh · 2015 [cited by applicant]
US 11617763B2 · Krishnan et al. · 2023 [cited by applicant]
US 20140024614A1 · Ghosh · 2014 [cited by applicant]
JP 2017014204A · 2017 [cited by applicant]
WO 0241901A1 · 2002 [cited by applicant]
WO 2008144836A1 · 2008 [cited by applicant]
WO 2012103588A1 · 2012 [cited by applicant]
WO 2013055734A1 · 2013 [cited by applicant]
Sinusas, American Family Physician, vol. 85, No. 1, 2012. (Year: 2012). [cited by examiner]
Notice of Allowance and Allowed Claims for AU Patent Appl. 2021201198, mailed Jun. 22, 2022. [cited by applicant]
Osteoarthritis, Treatment & management—Australian Institute of Health and Welfare, https://www.aihw.gov.au/reports/chronic-musculoskeletal-conditions/osteoarthritis/contents/treatment-management, accessed Jan. 9, 2022. [cited by applicant]
Altahawi, F.F. et al., “Comparing an accelerated 3D fast spin-echo sequence (CS-SPACE) for knee 3-T magnetic resonance imaging with traditional 3D fast spin-echo (SPACE) and routine 2D sequences”, Skeletal radiology; 46… [cited by applicant]
Anderson, V.R. et al., “Pentosan polysulfate: a review of its use in the relief of bladder pain or discomfort in interstitial cystitis”, Drugs; 66(6), 2006, 821-835. [cited by applicant]
Batemen, D. et al., “Non-steroidal anti-inflammatory drugs and elderly patients”, British Medical Journal; 310, 1995, 817-818. [cited by applicant]
Boks, S.S. et al., “Clinical consequences of posttraumatic bone bruise in the knee”, Am J Sports Med 2007; 35(6), 2007, 990-995. [cited by applicant]
Bonnin, M. et al., “Osteoarthritis of the Knee”, Springer-Verlag, France, 2008, 635 pages. [cited by applicant]
Brandt, K.D., “Should nonsteroidal anti-inflammatory drugs be used to treat osteoarthritis?”, Rheumatic Disease Clinics of North America; 19, 1993, 29-44. [cited by applicant]
Briggs, K.K. et al., “Reliability, validity, and responsiveness of the Lysholm knee score and Tegner activity scale for patients with meniscal injury of the knee”, The Journal of bone and joint surgery American vol. 88(… [cited by applicant]
Chaler, J. et al., “Painful lateral knee condyle bone marrow edema after treatment with lateral wedged insole”, Am J Phys Med Rehabil; 89(5), 2010, 429-433. [cited by applicant]
Davies, N.H. et al., “Magnetic resonance imaging of bone bruising in the acutely injured knee-short-term outcome”, Clin Radiol; 59(5), 2004, 439-445. [cited by applicant]
Davies-Tuck, M.L., “The natural history of bone marrow lesions in community-based adults with no clinical knee osteoarthritis”, Annals of the Rheumatic Diseases.; 68(6), 2009, 904-908. [cited by applicant]
Davis, E.L. et al., “Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial”, J Urol; 179(1), 2008, 177-185. [cited by applicant]
Dimitrakov, J. et al., “Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review”, Arch Intern Med; 167(18), 2007, 1922-1929. [cited by applicant]
Eriksen, E.F., “Treatment of bone marrow lesions (bone marrow edema)”, BoneKey Reports 4, Article No. 755, 2015. [cited by applicant]
Fairbank, J.C.T. et al., “The Owestery Disability Index”, Spine, 25(22), 2000, 2940-2953. [cited by applicant]
Fatiadou, A., “Wrist injuries in young adults: The diagnostic impact of CT and MRI”, Eur J Radiol., Jun. 14, 2010. [cited by applicant]
Felson, D.T., “Bone marrow edema and its relation to progression of knee osteoarthritis”, Annals of internal medicine;139(5 Pt 1), 2003, 330-336. [cited by applicant]
Felson, D.T. et al., “The association of bone marrow lesions with pain in knee osteoarthritis”, Annals of internal medicine;134(7), 2001, 541-549. [cited by applicant]
Ghosh, P. et al., “Effects of pentosan polysulfate in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled pilot study”, Current Ther Research; 6, 2005, 552-571. [cited by applicant]
Ghosh, P., “The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment”, Sem Arthritis Rheum; 28, 1999, 211-267. [cited by applicant]
Gonc, U. et al., “Bone bruises of the knee”, Acta Orthop Traumatol Turc; 41 Suppl 2, 2007, 98-104. [cited by applicant]
Hayashi, D. et al., “Semiquantitative assessment of subchondral bone marrow edema-like lesions and subchondral cysts of the knee at 3T MRI: A comparison between intermediate-weighted fatsuppressed spin echo and Dual Ech… [cited by applicant]
Hjermstad, M.J. et al., “Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review”, Journal of pain and sympt… [cited by applicant]
Hoffman, S. et al., “The painful bone marrow edema syndrome of the hip joint”, Wien Klin Wochenschr; 117(4), 2005, 111-120. [cited by applicant]
Hofmann, S. et al., “Painful bone marrow edema of the knee: differential diagnosis and therapeutic concepts”, Orthop. Clin. N. Am., 35, 2004, 321-333. [cited by applicant]
Hunter, et al., “The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston Leeds Osteoarthritis Knee Score)”, Ann. Rheum. Dis, 67, 2008, 206-211. [cited by applicant]
Hunter, D.J. et al., “Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis”, Arthritis and rheumatism; 54(5), 2006, 1529-1535. [cited by applicant]
Huskisson, E.C., “Effects of anti-inflammatory drugs on the progression of osteoarthritis of the knee”, Journal of Rheumatology; 22, 1995, 1941-1946. [cited by applicant]
Koo H-K, H-K et al., “Bone Marrow Edema and associated pain in early stage osteonecrosis of the femoral head: prospective study with serial MR images”, Radiology; 213, 1999, 715-722. [cited by applicant]
Kream, B., “Clinical and basic aspects of glucocorticord actions in bone”, Principle of Bone Biology vol. 1 Chapter 44; Eds: Bilezikian, Raisz LG, Roe GA. Elsevier B V Netherlands Academic Press New York, 2008. [cited by applicant]
Krupinski, K. et al., “Anticoagulant and antithrombotic effects of chemically modified heparins and pentosan polysulfate”, Haemostasis; 20(2), 1990, 81-92. [cited by applicant]
Kumagai, K. et al., “Sodium pentosan polysulfate resulted in cartilage improvement in knee osteoarthritis—an open clinical trial”, BMC Clin Pharm; 10, 2010, 1-9. [cited by applicant]
Kuttapitiya, et al., “Microarray analysis of bone marrow lesions in osteoarthritis demonstrates upregulation of genes implicated in osteochondral turnover, neurogenesis and inflammation”, Ann. Rheum. Dis., Oct. 2017;76(… [cited by applicant]
Laslett, L.L. et al., “Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial”, Ann Rheum Dis.; 71(8), 2012, 1322-1328. [cited by applicant]
Losonczy, H., “Effect of pentosan polysulfate on activated partial thromboplastin time, thrombin time, euglobulin clot lysis and tissue-type plasminogen activator and plasminogen activator inhibitor activities in patien… [cited by applicant]
Lovell, G. et al., “Osteitis pubis and assessment of bone marrow edema at the pubic synphysis with MRI in an elite junior male soccer squad”, Clin J Sport Med; 16(2), 2006, 117-122. [cited by applicant]
Lowitz, T., “Bone marrow lesions identified by MRI in knee osteoarthritis are associated with locally increased bone mineral density measured by QCT”, Osteoarthritis and cartilage.; 21(7), 2013, 957-964. [cited by applicant]
Masala, Salvatore et al., “Treatment of painful Modic type I changes by vertebral augmentation with bioactive resorbable bone cement”, Neuroradiology 56, 2014, pp. 637-645. [cited by applicant]
Mayerhoefer, M.E. et al., “Short-term outcome of painful bone marrow oedema of the knee following oral treatment with iloprost or tramadol: results of an exploratory phase II study of 41 patients”, Rheumatology; 46(9), … [cited by applicant]
Mckenzie, L.S. et al., “Effect of anti-inflammatory drugs on sulphated glycosaminoglycan synthesis in aged human articular cartilage”, Ann rheum Dis; 35(6), 1976, 487-497. [cited by applicant]
Miyata, N. et al., “Pentosan reduces osteonecrosis of femoral head in SHRSP”, Clinical and experimental hypertension (New York, NY : 1993); 32(8), 2010, 511-516. [cited by applicant]
Nakame, A. et al., “Natural history of bone bruises after acute knee injury: clinical outcome and histopathological findings”, Knee Surg Sports Traumatal Arthrose; 14, 2006, 1252-1258. [cited by applicant]
O'Loughlin, PF et al., “Current concepts in the diagnosis and treatment of osteochondral lesions of the ankle”, Am J Sports Med; 38, 2010, 392-404. [cited by applicant]
O'Mahony, D. , “Prevention of corticosteroid-induced osteoporosis and fractures”, Journal of Clinical Pharmacy and Therapeutics; 24(2), 1999, 83-85. [cited by applicant]
Omar, I.M. et al., “Athletic pubalgia and “sports hernia”: optimal MR imaging technique and findings”, Radiographies; 28(5), 2008, 1415-1438. [cited by applicant]
Orchard, J. et al., Injury Report—Australian Football League; Wednesday May 12, 2010., 2009. [cited by applicant]
Orr, JD et al., “Painful bone marrow edema syndrome of the foot and ankle”, Foot Ankle Int; 31(11), 2010, 949-953. [cited by applicant]
International Search Report and Written Opinion, App. No. PCT/AU2018/050816, Sep. 5, 2018, 13 pages. [cited by applicant]
Powell, S.E. et al., “Standing magnetic resonance imaging detection bone marrow oedema-type signal pattern associated with subcarpal pain in 8 racehorses: a prospective study”, Equine Vet J; 42(1), 2010, 10-17. [cited by applicant]
Radin, E.I., “The importance of bone in sparing articular cartilage from impact”, Clin Orthop Related Res.; 78, 1971, 342-344. [cited by applicant]
Radin, E.R., “The pathogenesis of primary osteoarthritis”, Lancet, Jun. 24, 1972, 1395-1396. [cited by applicant]
Rahme, R. et al., “The modic vertebral endplate and marrow changes: pathologic significance and relation to low back pain and segmental instability of the lumbar spine”, AJNR Am J Neuroradiol.; 29(5), May 2008, 838-842. [cited by applicant]
Raynauld, J.P. et al., “Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period”, Ann R… [cited by applicant]
Roemer, F.W., “Change in MRI-detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicentre study of knee osteoarthritis”, Ann Rheum Dis.; 68(9), 2009, 1461-1465. [cited by applicant]
Romas, E., “Corticosteroid-induced osteoporosis and fractures”, Australian Prescriber; 31(2), 2008, 45-49. [cited by applicant]
Roos, E.M. et al., “Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis”, Health Qual Life Outcomes; 1:64, 2003. [cited by applicant]
Sampson, Matthew J. et al., “Improved clinical outcome measures of knee pain and function with concurrent resolution of subchondral Bone Marrow Edema Lesion and joint effusion in an osteoarthritic patient following Pent… [cited by applicant]
Scully, M.F. et al., “Anticoagulant and antiheparin activities of a pentosan polysulphate”, Thrombosis Research; 31(1), 1983, 89-97. [cited by applicant]
Shanmugam, M. et al., “Heparinoid-active sulphated polysaccharides from marine algae as potential blood anticoagulant agents”, Current Science; 79(12), 2000, 1672-1683. [cited by applicant]
Starr, A.M. et al., “Bone marrow edema: pathophysiology, differential diagnosis, and imaging”, Acta radiologica (Stockholm, Sweden: 1987); 49(7), 2008, 771-786. [cited by applicant]
Szkopek, K. et al., “Pain and Knee function in relation to degree of bone bruise after acute anterior cruciate ligament rupture”, Scand J Med Sci Sports, doi: 10.1111/j.1600-0838.2011.01297.x. [Epub ahead of print], Apr… [cited by applicant]
Tanamas, S.K., “Bone marrow lesions in people with knee osteoarthritis predict progression of disease and joint replacement: a longitudinal study”, Rheumatology (Oxford, England); 49(12), 2010, 2413-2419. [cited by applicant]
Tanamas, S.K. et al., “The association between subchondral bone cysts and tibial cartilage volume and risk of joint replacement in people with knee osteoarthritis: a longitudinal study”, Arthritis Research and Therapy; … [cited by applicant]
Theologis, A. A. et al., “Evaluation of bone bruises and associated cartilage in anterior cruciat ligament injured and—reconstructed knees using quantitative 1 tesla magnetic resonance imaging”, 1-year cohort study. Art… [cited by applicant]
Thiryayi, WA, “Histopathological perspective on bone marrow oedema reactive bone change and haemorrhage”, Eur J Radiol; 67(1), 2008, 62-67. [cited by applicant]
Unay, K. et al., “The relationship between bone marrow edema size and knee pain”, Knee Surg Sports Traumatol Arthrosc; 17(11), 2009, 1298-1304. [cited by applicant]
Varenna, M. et al., “Intravenous neridronate in the treatment of acute painful knee osteoarthritis: a randomized controlled study”, Rheumatology (Oxford, England).; 54(10), 2015, 1826-1832. [cited by applicant]
Verrall, GM et al., “Incidence of pubic bone marrow oedema in Australian Rules football players: relation to groin pain”, Br J Sports Med; 35, 2001, 28-33. [cited by applicant]
Vinazzer, H., “Prevention of recurrence of cerebrovascular thromboses. A randomized comparative study acetylsalicylic acid and sodium pentosan polysulfate”, Fortschr Med; 105(5), 1987, 79-85. [cited by applicant]
Vongchan, P. et al., “Anticoagulant activities of the chitosan polysulfate synthesized from marine crab shell by semi-heterogeneous conditions”, Science Asia; 29, 2003, 115-120. [cited by applicant]
Voormolen, MHJ et al., “Bone marrow edema in osteoporotic vertebral compression fractures after percutaneous vertebroplasty and relation with clinical outcome”, American J Neuroradiology; 27, 2006, 983-988. [cited by applicant]
Werb, Z., “Biochemical actions of glycocorticoids on macrophages in culture. Specific in activator secretion and effects on other metabolic functions”, JEM; 147(6), 1978, 1695-1712. [cited by applicant]
Wikipedia, “Modic changes”, https://en.wikipedia.org/wiki/Modic_changes (Accessed Feb. 6, 2020), Jul. 21, 2017, 3 pages. [cited by applicant]
Wilkens, Philip et al., “No effect of 6-month intake of glucosamine sulfate on Modic changes or high intensity zones in the lumbar spine: sub-group analysis of a randomized controlled trial”, Journal of Negative Results… [cited by applicant]
Wluka, A.E. et al., “Bone marrow lesions predict increase in knee cartilage defects and loss of cartilage volume in middle-aged women without knee pain over 2 years”, Ann Rheum Dis; 68, 2009, 850-855. [cited by applicant]
Wluka, A.E. et al., “Bone marrow lesions predict progression of cartilage defects and loss of cartilage volume in healthy middle-aged adults without knee pain over 2 yrs”, Rheumatology (Oxford, England);47(9), 2008, 139… [cited by applicant]
Zhai, G. et al., “Correlates of knee pain in older adults: Tasmanian Older Adult Cohort Study”, Arthritis and rheumatism; 55(2), 2006, 264-271. [cited by applicant]
Kellgren-Lawrence Scale for radiographic classification of osteoarthritis—McMaster Textbook of Internal Medicine Table 18.13-1, https://empendium.com/mcmtextbook/table/031_0728; accessed Aug. 21, 2022. [cited by applicant]
Numeric Rating Scale (NRS), National Center for Biotechnology Information, U.S. National Library of Medicine, Medscape, National Center for Biotechnology Information, U.S. National Library of Medicine, www.painscale.com… [cited by applicant]
Jensen, Mark P., et al., Jensen et al., Interpretation of Visual Analog Scale Ratings and Change Scores: A Reanalysis of Two Clinical Trials of Postoperative Pain, The Journal of Pain, vol. 4, No. 7 Sep. 2003: pp. 407-4… [cited by applicant]